United States Cold Plasma In Healthcare Market with CAGR of 15.4% during 2022-2029 - Exclusive Report by DatamIntelligence

"The Cold Plasma In Healthcare Market is predicted to reach at a high CAGR of 15.4% during the forecast period (2022-2029)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cold-plasma-in-healthcare-market?sp

United States: Recent Industry Developments

✅ In July 2025, Adtec Healthcare secured $12 million in strategic investment from AIPO Fund and SG Biomedical to drive global expansion and advance next-generation Cold Plasma medical devices. The investment supports U.S. market entry and FDA regulatory approval efforts. It amplifies innovation in infection control and wound care with non-antibiotic plasma technology.

✅ In July 2025, Plasmacure obtained €6 million investment plus U.S. market financing from a strategic consortium to accelerate global expansion of its PLASOMA cold plasma technology for complex wound care. This funding boosts R&D, clinical validation, and commercial scaling. It enhances treatment options against multi-drug-resistant infections.

✅ In February 2025, Royal Biologics announced a strategic partnership with Coldplasmatech GmbH to transform treatments for complex and chronic wounds using advanced Cold Atmospheric Plasma systems. The collaboration focuses on combating multi-drug-resistant infections with class IIb medical devices registered in the EU. It raises efficacy in wound healing technology.

✅ In August 2025, USA companies Advanced Plasma Solutions and PlasmaTech Inc. pioneered innovative cold plasma applications across healthcare, food processing, and electronics sectors, driving market expansion with supportive regulatory frameworks and collaborations. These efforts strengthen U.S. leadership in cold plasma technology adoption.

Japan: Recent Industry Developments

✅ In July 2025, Adtec Plasma Technology Co., Ltd., the parent company of Adtec Healthcare, continued expanding its cold plasma technology leadership from Japan, with years of experience pioneering the first CE-marked cold plasma medical device for wound care and infection control. The company supports global healthcare innovation.

✅ In September 2025, Japan's cold plasma market growth remained robust, driven by rising demand in healthcare for advanced wound healing, cancer treatments, and sterilization technologies. The aging population and regulatory encouragement fuel investments and adoption of minimally invasive plasma therapies across hospitals and clinics.

✅ In June 2025, Japan's National Cancer Center highlighted cold plasma as a promising non-invasive cancer therapy option, selectively targeting cancer cells with minimal damage to healthy tissues. This aligns with Japan's strategic focus on improving oncology treatment outcomes and reducing side effects of traditional therapies.

✅ In early 2025, Japanese government investments through METI and collaborations with Horizon Europe funded cold plasma R&D for healthcare applications, supporting innovation in infection control, wound healing, and sterilization. These initiatives reinforce Japan's commitment to advanced, sustainable medical technologies.

Cold Plasma In Healthcare Market: Drivers

The cold plasma in healthcare market is witnessing rapid growth due to its versatile applications in wound healing, sterilization, and antimicrobial treatments. Cold plasma technology generates reactive species at low temperatures, enabling non-thermal disinfection and tissue regeneration without damaging surrounding healthy cells. Rising incidence of chronic wounds, surgical site infections, and antibiotic-resistant pathogens is driving adoption in hospitals and clinical settings. Advances in device engineering and plasma delivery systems are enhancing precision, safety, and treatment efficacy. Increasing research on plasma-assisted therapies for dermatology, oncology, and dental care is further fueling market expansion.

Technological innovations and integration with minimally invasive procedures are boosting the applicability of cold plasma across diverse medical fields. Growing awareness among healthcare providers and patients about non-invasive, effective treatment options is accelerating adoption. Regulatory approvals and clinical validation of plasma devices are supporting market credibility and acceptance. Collaborations between research institutions, medical device companies, and healthcare facilities are facilitating development of next-generation applications. With rising focus on infection control, wound management, and innovative therapies, the cold plasma in healthcare market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cold-plasma-in-healthcare-market?sp

Cold Plasma In Healthcare Market: Major Players

U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited.

Segment Covered in the Cold Plasma In Healthcare Market:

➥ By Application: Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications

➥ By Regime: Low-Pressure Plasma, Atmospheric Cold Plasma, Others

Research Process:

Both primary and secondary data sources have been used in the Cold Plasma In Healthcare Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Cold Plasma In Healthcare Market Research Industry:

➠ Who leads the Cold Plasma In Healthcare industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Cold Plasma In Healthcare market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Cold Plasma In Healthcare market growth?
➠ What are the dominant sales and distribution strategies in the Cold Plasma In Healthcare industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cold-plasma-in-healthcare-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.